Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001104659-20-056881

Chief Medical Officer acquired 140,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Deliargyris Efthymios Chief Medical Officer 2020-04-12 Grant or award +140,000 140,000 D
Derivatives
Deliargyris Efthymios Chief Medical Officer 2020-04-12 Grant or award · Stock Option (right to buy) +85,500 85,500 D
Loading xslF345X03/tm2018632-3_4.xml…